Cargando…

The advantages and limitations of mesenchymal stem cells in clinical application for treating human diseases

Detalles Bibliográficos
Autor principal:	Lee, Seoung Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Osteoporosis 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372808/ https://www.ncbi.nlm.nih.gov/pubmed/30775559 http://dx.doi.org/10.1016/j.afos.2018.11.083

Ejemplares similares

Hematopoietic and Mesenchymal Stem Cells in Biomedical and Clinical Applications
por: Rizvanov, Albert A., et al.
Publicado: (2016)

Advantages and limitations of using national survey datasets in child and adolescent research
por: Lee, Yoon
Publicado: (2021)

Mesenchymal Stem Cells: Characteristics, Function, and Application
por: Li, Zhongjun, et al.
Publicado: (2019)

Usage of Human Mesenchymal Stem Cells in Cell-based Therapy: Advantages and Disadvantages
por: Kim, Hee Jung, et al.
Publicado: (2017)

Clinical Perspectives of Mesenchymal Stem Cells
por: Kramer, Jan, et al.
Publicado: (2012)

The secretion profile of mesenchymal stem cells and potential applications in treating human diseases
por: Han, Yuyi, et al.
Publicado: (2022)

Mesenchymal Stem Cell Therapy in Nonhematopoietic Diseases
por: de Carvalho, Katherine Athayde Teixeira, et al.
Publicado: (2015)

Reanalysis of Genomic Sequencing Results in a Clinical Laboratory: Advantages and Limitations
por: Won, Dongju, et al.
Publicado: (2020)

Bedside Doppler ultrasound for the assessment of renal perfusion in the ICU: advantages and limitations of the available techniques
por: Schnell, David, et al.
Publicado: (2015)

Mesenchymal stem cells in autoimmune diseases: hype or hope?
por: Scherer, Hans U, et al.
Publicado: (2010)

Use of mesenchymal stem cells for chronic kidney disease
por: Chung, Byung Ha
Publicado: (2019)

Current Status and Perspectives of Human Mesenchymal Stem Cell Therapy
por: Choi, Jane Ru, et al.
Publicado: (2019)

Harnessing Proliferation for the Expansion of Stem Cell-Derived Pancreatic Cells: Advantages and Limitations
por: Oakie, Amanda, et al.
Publicado: (2021)

Mesenchymal stem cells to treat liver diseases
por: Eom, Young Woo, et al.
Publicado: (2020)

Preclinical models of congestive heart failure, advantages, and limitations for application in clinical practice
por: Saura, Marta, et al.
Publicado: (2022)

Clinical Applications of Mesenchymal Stem Cells in Chronic Diseases
por: Farini, Andrea, et al.
Publicado: (2014)

Clinical application of mesenchymal stem cells in rheumatic diseases
por: Wang, Yajing, et al.
Publicado: (2021)

Inlays, Their Advantages and Limitations
por: Johnson, C. N.
Publicado: (1900)

Current Status and Perspectives of Human Mesenchymal Stem Cell Therapy 2020
por: Choi, Jane Ru, et al.
Publicado: (2022)

Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges
por: He, Chengmei, et al.
Publicado: (2021)

Mesenchymal stem cell- and extracellular vesicle-based therapies for Alzheimer’s disease: progress, advantages, and challenges
por: Gonçalves, Renata Guedes de Jesus, et al.
Publicado: (2022)

Potential advantages of genetically modified mesenchymal stem cells in the treatment of acute and chronic liver diseases
por: Sani, Farnaz, et al.
Publicado: (2023)

Advancing mesenchymal stem cell therapy for asthma towards clinical translation
por: MacLoughlin, Ronan
Publicado: (2022)

Advantages and limitations of cytogenetic, molecular cytogenetic, and molecular diagnostic testing in mesenchymal neoplasms
por: Bridge, Julia A.
Publicado: (2008)

Unflattened photon beams from the standard flattening filter free accelerators for radiotherapy: Advantages, limitations and challenges
por: Sharma, Sunil Dutt
Publicado: (2011)

Clinical applications of mesenchymal stem cells
por: Wang, Shihua, et al.
Publicado: (2012)

Clinical applications of mesenchymal stem cells
por: Kim, Nayoun, et al.
Publicado: (2013)

Challenges and Limitations of Strategies to Promote Therapeutic Potential of Human Mesenchymal Stem Cells for Cell-Based Cardiac Repair
por: Bui, Thi Van Anh, et al.
Publicado: (2021)

An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry
por: Weiss, Daniel J., et al.
Publicado: (2022)

Mesenchymal Stem Cells and Regenerative Medicine
por: Sumer, Huseyin, et al.
Publicado: (2018)

The Immunomodulatory Properties of Mesenchymal Stem Cells
por: Xu, Junji, et al.
Publicado: (2018)

Special Issue “The Role of Mesenchymal Stem Cells on Inflammatory and Fibrotic Diseases”
por: Di Vincenzo, Mariangela, et al.
Publicado: (2023)

Corrigendum: Preclinical models of congestive heart failure, advantages and limitations for application in clinical practice
por: Saura, Marta, et al.
Publicado: (2022)

Mesenchymal Stem/Stromal Cell Therapeutic Features: The Bridge between the Bench and the Clinic
por: Merimi, Makram, et al.
Publicado: (2021)

Lysyl Oxidase at the Crossroads of Mesenchymal Stem Cells and Epithelial-Mesenchymal Transition
por: Thomas, Clémence, et al.
Publicado: (2013)

Limited advantage of sugammadex reversal over the traditional neuromuscular reversal technique in terms of postoperative recovery of bowel function
por: Kim, Duk Kyung
Publicado: (2020)

Editorial for the Special Issue: “Current Technique for Antibiotic Susceptibility Test: Advantages and Limitations; Need for Next-Generation Test”
por: Nicolai, Eleonora
Publicado: (2023)

The advantages of mapping slow brain potentials using DC‐coupled graphene micro‐transistors: Clinical and translational applications
por: Wykes, Rob. C, et al.
Publicado: (2022)

Clinical applications of mesenchymal stem cells in chronic lung diseases
por: Antoniou, Katerina M., et al.
Publicado: (2018)

Advantages and pitfalls of clinical application of sugammadex
por: Lee, Hyung Young, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cg9omjujtapor5g751p68ps09e